An internist's update on cholesterol management.
Coronary heart disease (CHD) remains the leading cause of death in the United States. It is now well established that cholesterol is an important, reversible risk factor for CHD. This article provides a brief background on classification of the dyslipidemias, then discusses current recommendations for the evaluation and treatment of hyperlipidemia. Other risk factors currently being investigated as they relate to the development of CHD are discussed.
Holman
Honey East
HE
Department of Medicine, University of Mississippi Medical Center, Jackson 39216-4505, USA. hholman@medicine.umsmed.edu
Hicks
G Swink
GS
Low
Annette K
AK
Bouldin
Marshall J
MJ
Russell
Lori D
LD
Friedrich
Christopher A
CA
Brown
C Andrew
CA
D000483:Alleles; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D015992:Body Mass Index; D002784:Cholesterol / Q000378:metabolism*; D003327:Coronary Disease / Q000517:prevention & control*; D006801:Humans; D006949:Hyperlipidemias / Q000145:classification / Q000628:therapy; D008077:Lipoproteins, LDL / Q000378:metabolism; D012307:Risk Factors
D000924:Anticholesteremic Agents; D008077:Lipoproteins, LDL; D002784:Cholesterol